Advancing Management of Pediatric Celiac Disease: Genetics, Diagnosis, and Health Trajectories


Authors : Syed Khaja Ayaanuddin; Arian Hizomi; Satisy Soju; Dr Ana Chagiashvili; Syeda Fatima Zehra; Shiona Maria Bennetict; Maheshwaran Sundaramoorthy

Volume/Issue : Volume 10 - 2025, Issue 6 - June


Google Scholar : https://tinyurl.com/2h329sbd

DOI : https://doi.org/10.38124/ijisrt/25jun526

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.


Abstract : Aim: The purpose of this review isto investigate the complexity of celiac disease (CD) in the pediatric population, specifically the genetics, immunology, microbiology, nutrition, association of comorbidities such as type 1 diabetes mellitus (T1DM), neurodevelopmental disorders, and congenital hypothyroidism, as well as promising new diagnostics and therapeutics, including a gluten-free diet (GFD).  Methods: A thorough investigative analysis was conducted with 22 peer-reviewed journal publications from 1987 to 2024. The review papers cited original research, reviews, and clinical papers from PubMed and ScienceDirect. The analysis and review papers reported key themes of: (1) genetic susceptibility, (2) gut microbiome, (3) comorbidities and complications in children, (4) diagnostics, and (5) therapeutics, including GFD and pharmacological therapy.  Results: Genetic predisposition is a significant factor of CD, especially the HLA-DQ2 and DQ8 alleles(Sollid et al., 2021; Liu et al., 2020), although they are not the only loci that are having non-HLA loci having significance with CD. Patients with CD are at significantly higher risk to develop co- existing autoimmune and endocrine disorders such as T1DM and congenital hypothyroidism (Stagi et al., 2011; Lewandowska et al., 2018). Additionally, studies indicated a connection between CD and neurodevelopmental disorders, including altered urine peptide profiles, and vitamin D function (Bojović et al., 2019). Gut microbiome is more likely a risk factor rather than a consequence in CD, with dysbiosis impairing gluten immune tolerance (Cukrowska et al., 2021; Zhang et al., 2023). Nutritional deficiencies resulting from malabsorption and on dietary restrictions may create growth delays, micronutrient deficiencies, and mental health issues. (Fritsch et al., 2010; Lifshitz & Tarim, 1993). The GFD is the current standard of care, however a strict GFD continues to be less than optimal in more pediatric cases. Promising new pharmacological therapy, and revolutionary enzyme therapy, are underway (Leffler et al., 2022). Promising diagnostics are based on high- throughput testing; specifically, new microbiome profiling in the early and ongoing diagnosis (Lebwohl et al., 2020; Green et al., 2020). Further, and continuous, development of digital health technologies aimed toward optimizing care and access for children with CD. Conclusion: Celiac disease in children represents not only a gastrointestinal disease but a systemic condition with broad implications for immunology, metabolism, and even psychosocial influences. Genetic and serological screening in the early stages of diagnosis is important for determining CD, with microbiome aware strategies, especially for at-risk groups. The GFD is and will continue to be important, but personalized medicine, including digital health and targeted pharmacotherapy, provides the future direction toward a more comprehensive and sustainable management strategy in the pediatric population

References :

  1. Ascher, H. (2002). Paediatric aspects of coeliac disease: Old challenges and new ones. Digestive and Liver Disease, 34(11), 792–795. https://pubmed.ncbi.nlm.nih.gov/11990395/
  2. Bojović, K., Stanković, B., Kotur, N., Krstić-Milošević, D., Gašić, V., Pavlović, S., Zukić, B., & Ignjatović, Đ. (2019). Genetic predictors of celiac disease, lactose intolerance, and vitamin D function and presence of peptide morphins in urine of children with neurodevelopmental disorders. Nutritional Neuroscience. https://pubmed.ncbi.nlm.nih.gov/28738753/
  3. Cukrowska, B., Sowińska, A., Bierła, J. B., Czarnowska, E., & Grzybowska- Chlebowczyk, U. (2021). The role of the gut microbiome in celiac disease. Gut, 70(8), 1461–1471. https://doi.org/10.1136/gutjnl-2020-321504
  4. DeGeeter, C., & Guandalini, S. (2018). Food sensitivities: Fact versus fiction. Pediatric Gastroenterology, 27(4), 243–249.
  5. https://www.sciencedirect.com/science/article/pii/S0889855318300682
  6. Fritsch, S. L., Overton, M. W., & Robbins, D. R. (2010). The interface of child mental health and juvenile diabetes mellitus. Interface Between Pediatrics and Children's Mental Health, 3(2), 89–102. https://www.sciencedirect.com/science/article/pii/S105649931000009X
  7. Fritsch, S. L., Overton, M. W., & Robbins, D. R. (2015). The interface of child mental health and juvenile diabetes mellitus. Mental Health in the Medical Setting, 2, 135–144. https://www.sciencedirect.com/science/article/pii/S0193953X1400104X
  8. Green, P. H., Lebwohl, B., & Greywoode, R. (2020). Celiac disease: Current perspectives on diagnosis and treatment. The Lancet Gastroenterology & Hepatology, 5(5), 302–312. https://doi.org/10.1016/S2468-1253(19)30410-X
  9. Jankowska, M., Szadkowska, A., Pietrzak, I., Chrzanowski, J., Sołek, J., Fendler, W., & Mianowska, B. (2024). Assessment of skin autofluorescence and its association with glycated hemoglobin, cardiovascular risk markers, and concomitant chronic diseases in children with type 1 diabetes. Nutrients. https://pubmed.ncbi.nlm.nih.gov/38931293/
  10. Juto, P., Meeuwisse, G., & Mincheva-Nilsson, L. (1994). Why has coeliac disease increased in Swedish children? The Lancet, 344(8932), 1653–1654. https://www.sciencedirect.com/science/article/pii/S0140673694925143
  11. Lawrence, R. A., & Lawrence, R. M. (2011). Breastfeeding infants with problems. In
  12. Breastfeeding: A Guide for the Medical Profession (8th ed., pp. 299–328). https://www.sciencedirect.com/science/article/pii/B9781437707885100148
  13. Lebwohl, B., Greywoode, R., & Green, P. H. R. (2020). Digital health and celiac disease: Opportunities and challenges in patient care. JAMA, 324(11), 1119–1120. https://doi.org/10.1001/jama.2020.15599
  14. Lebwohl, B., Ludvigsson, J. F., & Green, P. H. R. (2018). Celiac disease and its long-term health consequences. The American Journal of Gastroenterology, 113(3), 413–419. https://doi.org/10.1038/ajg.2017.421
  15. Leffler, D. A., Green, P. H. R., & Fasano, A. (2022). Pharmacologic treatment for celiac disease: A future therapeutic strategy. Gastroenterology, 162(2), 494–505. https://doi.org/10.1053/j.gastro.2021.09.034
  16. Lewandowska, K., Ciepiela, O., Szypowska, A., Wyhowski, J., Głodkowska-Mrówka, E., Popko, K., Ostafin, M., Pyrżak, B., & Demkow, U. (2018). Celiac antibodies in children with type 1 diabetes – A diagnostic validation study. Autoimmunity, 51(2), 79–83. https://pubmed.ncbi.nlm.nih.gov/29350070/
  17. Lifshitz, F., & Tarim, Ö. (1993). Nutritional dwarfing. Current Problems in Pediatrics, 23(1), 1–25. https://www.sciencedirect.com/science/article/pii/0045938093900236
  18. Liu, E., Lee, H. S., Aronsson, C. A., & Rewers, M. (2020). New insights into the genetics of celiac disease: More than just HLA-DQ. The American Journal of Human Genetics, 107(1), 41–51. https://doi.org/10.1016/j.ajhg.2020.05.012
  19. Murray, J. A., Rubio-Tapia, A., & Fasano, A. (2020). Long-term outcomes of untreated celiac disease: A follow-up of childhood diagnosed celiac disease. Current Opinion in Gastroenterology, 36(3), 228–235. https://doi.org/10.1097/MOG.0000000000000627
  20. Polanco, I., Mearin, M. L., Larrauri, J., Biemond, I., Wipkink-Bakker, A., & Peña, A. S. (1987). Effect of gluten supplementation in healthy siblings of children with celiac disease. Gastroenterology, 93(3), 703–709.
  21. https://www.sciencedirect.com/science/article/pii/0016508587900175
  22. Sollid, L. M., Molberg, Ø., McAdam, S. N., & Lundin, K. E. A. (2021). The HLA-DQ locus and celiac disease. Nature Reviews Gastroenterology & Hepatology, 18(2), 123–134. https://doi.org/10.1038/s41575-020-00360-3
  23. Stagi, S., Manoni, C., Cecchi, C., Chiarelli, F., & de Martino, M. (2011). Increased risk of coeliac disease in patients with congenital hypothyroidism. Hormone Research in Paediatrics, 76(3), 180–185. https://pubmed.ncbi.nlm.nih.gov/21757873/
  24. Wolfsdorf, J. I., Botero, D., Jameson, J. L., & De Groot, L. J. (2010). Management of diabetes mellitus in children. In Endocrinology: Adult and Pediatric (pp. 765–785). https://www.sciencedirect.com/science/article/pii/B9781416055839000496
  25. Zhang, X., et al. (2023). Microbiome profiling as a non-invasive diagnostic tool for celiac disease. Nature Medicine, 29(5), 1111–1118. https://doi.org/10.1038/s41591-023-02345-6

Aim: The purpose of this review isto investigate the complexity of celiac disease (CD) in the pediatric population, specifically the genetics, immunology, microbiology, nutrition, association of comorbidities such as type 1 diabetes mellitus (T1DM), neurodevelopmental disorders, and congenital hypothyroidism, as well as promising new diagnostics and therapeutics, including a gluten-free diet (GFD).  Methods: A thorough investigative analysis was conducted with 22 peer-reviewed journal publications from 1987 to 2024. The review papers cited original research, reviews, and clinical papers from PubMed and ScienceDirect. The analysis and review papers reported key themes of: (1) genetic susceptibility, (2) gut microbiome, (3) comorbidities and complications in children, (4) diagnostics, and (5) therapeutics, including GFD and pharmacological therapy.  Results: Genetic predisposition is a significant factor of CD, especially the HLA-DQ2 and DQ8 alleles(Sollid et al., 2021; Liu et al., 2020), although they are not the only loci that are having non-HLA loci having significance with CD. Patients with CD are at significantly higher risk to develop co- existing autoimmune and endocrine disorders such as T1DM and congenital hypothyroidism (Stagi et al., 2011; Lewandowska et al., 2018). Additionally, studies indicated a connection between CD and neurodevelopmental disorders, including altered urine peptide profiles, and vitamin D function (Bojović et al., 2019). Gut microbiome is more likely a risk factor rather than a consequence in CD, with dysbiosis impairing gluten immune tolerance (Cukrowska et al., 2021; Zhang et al., 2023). Nutritional deficiencies resulting from malabsorption and on dietary restrictions may create growth delays, micronutrient deficiencies, and mental health issues. (Fritsch et al., 2010; Lifshitz & Tarim, 1993). The GFD is the current standard of care, however a strict GFD continues to be less than optimal in more pediatric cases. Promising new pharmacological therapy, and revolutionary enzyme therapy, are underway (Leffler et al., 2022). Promising diagnostics are based on high- throughput testing; specifically, new microbiome profiling in the early and ongoing diagnosis (Lebwohl et al., 2020; Green et al., 2020). Further, and continuous, development of digital health technologies aimed toward optimizing care and access for children with CD. Conclusion: Celiac disease in children represents not only a gastrointestinal disease but a systemic condition with broad implications for immunology, metabolism, and even psychosocial influences. Genetic and serological screening in the early stages of diagnosis is important for determining CD, with microbiome aware strategies, especially for at-risk groups. The GFD is and will continue to be important, but personalized medicine, including digital health and targeted pharmacotherapy, provides the future direction toward a more comprehensive and sustainable management strategy in the pediatric population

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe